Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Developers
Trial Sites
Trials
Clinical Pipeline
Clinical Pipeline
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
Study Director
Michael Hoelscher
Start Date
10 / 2019
Trial Phase
Phase I
Trial Status
study in development
Current Enrollment
Target Enrollment
77
Overview
Registry Link
Developer Associations
University of Munich
EDCTP
Compound Associations
BTZ-043